Condensed Consolidating Financial Statements - Additional Information (Details) |
Jan. 21, 2020
USD ($)
Debtinstrument
|
|---|---|
| Iterum Therapeutics Bermuda Limited | |
| Condensed Financial Statements Captions [Line Items] | |
| Ownership percentage | 100.00% |
| Subsidiary Guarantors | |
| Condensed Financial Statements Captions [Line Items] | |
| Ownership percentage | 100.00% |
| Private Placement | 2025 Exchangeable Notes | |
| Condensed Financial Statements Captions [Line Items] | |
| Aggregate principal amount | $ 51,600,000 |
| Debt instrument price per unit | 1,000 |
| Private Placement | RLNs | |
| Condensed Financial Statements Captions [Line Items] | |
| Aggregate principal amount | $ 100,000 |
| Number of debt instruments within each notes | Debtinstrument | 50 |
| X | ||||||||||
- Definition Number of debt instruments within each unit. No definition available.
|
| X | ||||||||||
- Definition Unit price per debt instrument. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|